RVMD Revolution Medicines, Inc.: Multiplikator nilai perusahaan marang pendapatan

Simbol resmi perusahaan revmed.com (RVMD)

Revolution Medicines (RVMD) complies with environmental regulations regarding bio-waste disposal. The EV-to-revenue multiple visualizes the purity of market value excluding debt load, where 162196.29 determines the latest valuation metric. The business relies on the unique development of RAS protein inhibitors to combat advanced cancer. The chronic nature of these pathologies ensures stable, multi-year demand for patented therapy methods.

RevMed (RVMD) - Nilai perusahaan marang pendapatan saka 23.11.2025 nganti 20.11.2026

Revolution Medicines Corp - rincian analitis lan metrik utama (RVMD)

- rega saham lan prakiraan rega para ahli:
- data saldo dhuwit lan arus kas:
Analisis wiwitan perusahaan:RVMD, revmed.com
Produk sing diprodhuksi RevMed

Amid intense competition in the development of anti-cancer drugs, the current enterprise value-to-revenue multiple of Revolution Medicines (RVMD) allows for an assessment of market expectations for future therapies, excluding debt obligations. This ratio compares the total business value to its annual turnover, helping investors determine the degree of asset overvaluation and the risks of correction in the event of potential clinical trial failures.

Analisis pesaing

Rasio nilai perusahaan marang dodolan BeiGene Ltd (ONC)|Halozyme Corp (HALO) - Rasio nilai perusahaan marang pendapatan|Multiplikator nilai perusahaan marang pendapatan Ascentage Pharma Group International (AAPG)|Rasio nilai perusahaan marang pendapatan CG Oncology, Inc.|Multiplikator nilai perusahaan marang pendapatan UroGen Pharma Corp URGN|Multiplikator EV/Sales BCAX|Personalis, Inc. - Rasio nilai perusahaan marang pendapatan|Erasca - Nilai perusahaan marang pendapatan|Nilai bisnis marang pendapatan DCTH|YMAB: Nilai perusahaan marang pendapatan|Multiplikator nilai perusahaan marang pendapatan Aura Corp|CADL: Multiplikator EV/Sales|ARAY - Rasio total nilai perusahaan marang pendapatan|SLS (SELLAS Life Sciences Group, Inc.) - Multiplikator EV/Sales|ACTU: Nilai bisnis marang pendapatan|Rasio nilai perusahaan marang pendapatan citiusonc.com (CTOR)|Rasio total nilai perusahaan marang pendapatan TuHURA Biosciences|Rasio nilai perusahaan marang pendapatan Protara Therapeutics TARA|Fate Therapeutics (FATE) - Multiplikator nilai perusahaan marang pendapatan|WHWK - Rasio nilai perusahaan marang pendapatan|Multiplikator nilai perusahaan marang pendapatan TScan Therapeutics Inc|championsoncology.com (CSBR) - Rasio nilai perusahaan marang pendapatan|Rasio nilai perusahaan marang pendapatan XBIT|Nilai perusahaan marang pendapatan CVM|Rasio nilai perusahaan marang pendapatan OSTX (OS Therapies Incorporated)|Multiplikator EV/Sales RADX|ARTV: Nilai perusahaan marang volume dodolan|Multiplikator EV/Sales ANL (Adlai Nortye Ltd)|VERU - Nilai perusahaan marang pendapatan|tempesttx.com - Multiplikator EV/Sales|Nilai bisnis marang pendapatan XLO (xiliotx.com)|RENB: Multiplikator EV/Sales|Nilai perusahaan marang pendapatan Mural Oncology plc|Rasio nilai perusahaan marang pendapatan Kairos Pharma Inc|OKUR: Nilai bisnis marang pendapatan|Multiplikator EV/Sales GDTC|CRIS (Curis) - Nilai bisnis marang pendapatan|Rasio nilai perusahaan marang pendapatan apollomicsinc.com APLM|THAR: Rasio nilai perusahaan marang pendapatan|advanbiomed.com - Multiplikator EV/Sales|Nilai bisnis marang pendapatan GNPX (Genprex, Inc)|Calidi Biotherapeutics Inc. (CLDI) - Rasio nilai perusahaan marang pendapatan|Sunshine Biopharma Inc. (SBFM) - Multiplikator EV/Sales|XBIO (Xenetic Bio) - Multiplikator EV/Sales|Salarius Pharmaceuticals Inc (SLRX) - Rasio total nilai perusahaan marang pendapatan|Multiplikator EV/Sales PPBT|Multiplikator EV/Sales American Oncology Network Inc (AONC)|Multiplikator EV/Sales BGNE (BeiGene Ltd.)|Koefisien nilai perusahaan marang pendapatan CKPT (Checkpoint Therapeutics)|ELEV - Rasio nilai perusahaan marang pendapatan|ICAD (iCAD Inc.) - Rasio nilai perusahaan marang pendapatan|Ikena (IKNA) - Rasio nilai perusahaan marang pendapatan|Nilai perusahaan marang pendapatan Notable Labs, Ltd.|Rasio nilai perusahaan marang pendapatan viracta.com|MOR: Nilai bisnis marang pendapatan|Multiplikator EV/Sales NAYA|Ascentage Pharma - Rasio nilai perusahaan marang pendapatan